CoMFA and docking studies on triazolopyridine oxazole derivatives as p38 MAP kinase inhibitors

MRS Nayana, YN Sekhar, NS Kumari… - European Journal of …, 2008 - Elsevier
With the objective to design new chemical entities with enhanced inhibitory potencies
against p38 MAP alpha kinase, the 3D-QSAR and Comparative Molecular Field Analysis …
被引用次数：55 相关文章

CoMFA and docking studies on triazolopyridine oxazole derivatives as p38 MAP kinase inhibitors.

SN MR, YN Sekhar, SK Mahmood… - European Journal of …, 2007 - europepmc.org
With the objective to design new chemical entities with enhanced inhibitory potencies
against p38 MAP alpha kinase, the 3D-QSAR and Comparative Molecular Field Analysis …

CoMFA and docking studies on triazolopyridine oxazole derivatives as p38 MAP kinase inhibitors

MRS Nayana, YN Sekhar, NS Kumari… - European Journal of …, 2008 - infona.pl
With the objective to design new chemical entities with enhanced inhibitory potencies
against p38 MAP alpha kinase, the 3D-QSAR and Comparative Molecular Field Analysis …

CoMFA and docking studies on triazolopyridine oxazole derivatives as p38 MAP kinase inhibitors

MRS Nayana, YN Sekhar… - European journal …, 2008 - pubmed.ncbi.nlm.nih.gov
With the objective to design new chemical entities with enhanced inhibitory potencies
against p38 MAP alpha kinase, the 3D-QSAR and Comparative Molecular Field Analysis …